Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06508580 · ClinicalTrials.gov registry record · NA
Optimizing Self-Monitoring Feedback for the Treatment of Obesity
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT06508580: Completed NA study, sponsored by University of Florida.
NCT06508580 is a NA study that has completed, run by University of Florida. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06508580, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Self-monitoring (of weight, intake, and activity) is a core component in evidence-based lifestyle interventions for obesity. Research has shown that interventionist feedback increases adherence to self-monitoring and improves weight loss outcomes; however, little empirical evidence exists on how this feedback should be provided. This research study aims to optimize the provision of self-monitoring feedback.
Primary Outcome
Weight will be assessed using the study-provided e-scales
Interventions
- BEHAVIORAL Component 1: Calorie Goal Attainment
- BEHAVIORAL Component 2: Diet Quality
- BEHAVIORAL Component 3: Physical Activity Goal Attainment
- BEHAVIORAL Component 4: Goal Setting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2024-07-23 |
| Est. Completion | 2025-02-03 |
| Phase | NA |
What the finished NCT06508580 record still lists
NCT06508580 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Component 1: Calorie Goal Attainment is the first listed.
NCT06508580 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06508580 about?
NCT06508580 is a clinical study titled "Optimizing Self-Monitoring Feedback for the Treatment of Obesity". Self-monitoring (of weight, intake, and activity) is a core component in evidence-based lifestyle interventions for obesity. Research has shown that interventionist feedback increases adherence to self-monitoring and improves weight loss outcomes; however, little empirical evidence exists on how thi...
What is the current status of trial NCT06508580?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2024-07-23. Estimated completion is 2025-02-03.
What interventions are being tested in trial NCT06508580?
The interventions under investigation include: Component 1: Calorie Goal Attainment (BEHAVIORAL), Component 2: Diet Quality (BEHAVIORAL), Component 3: Physical Activity Goal Attainment (BEHAVIORAL), Component 4: Goal Setting (BEHAVIORAL).
Who is sponsoring clinical trial NCT06508580?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06508580's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI